Diabetes Alert: Insulin Syringes Recalled

Company Recalls 471,000 ReliOn Insulin Syringes Because of Possible Mislabeling and Overdose Risk

From the WebMD Archives

Nov. 6, 2008 -- People with diabetes who use ReliOn insulin syringes should check their syringe package because of an important recall.

Tyco Healthcare Group (Covidien) is recalling 4,710 boxes of the syringes -- with 100 syringes in each box -- that were sold at Wal-Mart and Sam's Club from Aug. 1, 2008 through Oct. 8, 2008.

The reason for the recall: possible mislabeling and overdose risk.

"The use of these syringes may lead to patients receiving an overdose of as much as 2.5 times the intended dose, which may lead to hypoglycemia, serious health consequences, and even death," states an FDA news release.

The recall only applies to the following products:

  • Product name: ReliOn Insulin Syringes -- 31 gauge 1 cc (with 100 syringes per box)
  • Lotnumber: 813900 (on the back panel of the carton, or on the white paper backing of each syringe's "peel pack")
  • Product identification number: 38396-0403-02 (on the top panel upper right-hand corner of the syringe box)

The FDA says some syringes labeled for use with U-40 insulin got packaged with syringes for U-100 insulin.

The FDA notes that Tyco Healthcare recalled this lot of syringes in October, and Wal-Mart and Sam's Club stores have posted information about the recall and notified more than 16,500 customers about the recall.

For more information, call 866-780-05436 or visit the ReliOn recall web site for more information. Customers will be provided with a replacement package.

WebMD Health News Reviewed by Louise Chang, MD on November 06, 2008



News release, FDA.


© 2008 WebMD, LLC. All rights reserved.